期刊文献+

恶性淋巴瘤发病与病毒感染的配对病例-对照研究 被引量:3

A Paired Case-control Study for Assessing the Relationship Between the Incidence of Malignant Lymphomas and the Viruses Infections
下载PDF
导出
摘要 目的 评价四川地区病毒感染与恶性淋巴瘤 (ML )发病的关系。方法 采用配对病例 -对照研究设计方案。病例组 :97例确诊的淋巴瘤病例。对照组 A :194例按性别、年龄因素配对的同期随机选择的非肿瘤病例。对照组 B(EB病毒对照组 ) :其它非肿瘤病例 80例。采用酶联免疫法 (EL ISA法 )检测丙型肝炎病毒 (HCV)、人类免疫缺陷病毒 (HIV )、巨细胞病毒 (CMV)和乙型肝炎病毒 (HBV )抗体及抗原。用 EBER原位杂交法 (EBER- ISH )检测病理组织中 EB病毒 (EBV)。结果  EBV阳性率 ML组 70 .1% (6 8/ 97) ,对照组 7.5 % (6 / 80 ) ,OR=6 .5 8,95 % CI:16 .16 4~ 82 .84 6 ,P=0 .0 0 0 1。病例组与对照组感染 HCV、CMV、HBV差异的 P值分别为 0 .2 6 0、0 .2 5 8、0 .6 74(HBV小三阳 )、0 .399(HBV大三阳 )、0 .74 4 (HBV表面抗体阳性 )。 HIV病例组与对照组均无阳性检出。结论 本地区 EBV感染与淋巴瘤发病有相关性 ,而 HCV、HBV、HIV和 Objective To evaluate the relationships between the viruses infections and the incidence of malignant lymphomas(ML) in Sichuan province. Methods A hospital-based paired case-control study was designed with two controls per case. The case group comprised 97 cases diagnosed as ML by pathological examination; the control group A consisted of 194 subjects randomly selected from those with non-malignancies by matching on both gender and age in the corresponding period. Additionally, a control group B for Epstein-Barr virus(EBV), including 80 subjects, were chosen from other non-malignant diseases at the same time. Enzyme-linked immunosorbent assay(ELISA) was employed to test the serum antibodies and antigens of hepatitis C virus (HCV), human immunodeficiency virus (HIV), cytomegalovirus (CMV), and hepatitis B virus (HBV). The EBV was confirmed by the EBER in situ-hybridization (EBER-ISH) of pathological tissue. Results The positive rate of EBV in ML group was 70.1%(68/97) and that of control group was 7.5%(6/80). The difference between these two groups showed a statistical significance by conditional logistic regression analysis(OR=6.58, 95% CI: 16.164-82.846, P=0.0001). The differences in HCV, CMV and HBV infections between case group and control group demonstrated no statistical significance with P-values of 0.260, 0.258 and 0.399 respectively. We found no positive results of HIV antibody in case group and control group. Conclusion The incidence of ML in Sichuan displayed a significant association with EBV infection. However, there were no relationships between the incidence of ML and the HCV, HBV, HIV, CMV infections in the area.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2004年第2期247-250,共4页 Journal of Sichuan University(Medical Sciences)
关键词 恶性淋巴瘤 病毒 感染 病因 Malignant lymphoma Virus Infection Etiology
  • 相关文献

参考文献2

二级参考文献7

共引文献12

同被引文献31

  • 1黄小梅.重庆市人口老龄化的现状及对策研究[J].重庆行政(公共论坛),2013,14(2):54-56. 被引量:29
  • 2何晖,翟明,Laurie.L.Chen,张岱.淋巴细胞恶性增生性疾病患者肝炎病毒感染状况的分析[J].白血病.淋巴瘤,2005,14(5):299-301. 被引量:2
  • 3杨功焕,王俊芳,万霞,王黎君,陈爱平.影响中国人群疾病死亡因素的定量分析[J].中华流行病学杂志,2005,26(12):934-938. 被引量:80
  • 4Feederle R, Kost M,Baumann M,et al.The Epstein-Barr virus lytic program is controlled by the co-operatice functions of two transactivators.EMBO J,2000;19(12):3080.
  • 5Pingfan Liu,Samuel H. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.Virology,2003;310(2):199.
  • 6Feng P, Ren EC,Liu D,et al. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.J Gen Virol ,2000;81(10):2417.
  • 7Bollag DM,Rozycki MD, Edelstein SJ. Protein Methods.New York:Wiley-Liss,1996:68-69.
  • 8Chang LK,ST Liu. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation:Nucleic Acids Res,2000;28(20):3918.
  • 9Feng WH, Westphal E, Mauser A, et al. Use of adenovirus vectors expressing Epstein-Barr virus immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.Virol,2002;76(21):10951.
  • 10Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol, 1994, 88: 392-394.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部